Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

582 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).
Papp KA, Langley RG, Lebwohl M, Krueger GG, Szapary P, Yeilding N, Guzzo C, Hsu MC, Wang Y, Li S, Dooley LT, Reich K; PHOENIX 2 study investigators. Papp KA, et al. Among authors: reich k. Lancet. 2008 May 17;371(9625):1675-84. doi: 10.1016/S0140-6736(08)60726-6. Lancet. 2008. PMID: 18486740 Clinical Trial.
Approach to managing patients with nail psoriasis.
Reich K. Reich K. J Eur Acad Dermatol Venereol. 2009 Sep;23 Suppl 1:15-21. doi: 10.1111/j.1468-3083.2009.03364.x. J Eur Acad Dermatol Venereol. 2009. PMID: 19686381 Review.
Nail psoriasis in Germany: epidemiology and burden of disease.
Augustin M, Reich K, Blome C, Schäfer I, Laass A, Radtke MA. Augustin M, et al. Among authors: reich k. Br J Dermatol. 2010 Sep;163(3):580-5. doi: 10.1111/j.1365-2133.2010.09831.x. Epub 2010 Apr 28. Br J Dermatol. 2010. PMID: 20456340
582 results